Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Recruiting

Phase 2

ENV-294Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Sponsor:

Enveda Therapeutics

Code:

NCT07298395

Conditions

Atopic Dermatitis (AD)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ENV-294

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-02. This information was provided to ClinicalTrials.gov by Enveda Therapeutics on 2025-12-23.